Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹1,097 Cr₹1,163 Cr₹1,809 Cr₹867 Cr₹903 Cr

What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA is ₹1,097 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹1,097 Cr
Mar2025₹1,163 Cr
Mar2024₹1,809 Cr
Mar2023₹867 Cr
Mar2022₹903 Cr

How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹1,097 Cr
-5.68
Mar2025 ₹1,163 Cr
-35.72
Mar2024 ₹1,809 Cr
108.67
Mar2023 ₹867 Cr
-4.01
Mar2022 ₹903 Cr -

Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹98,968.8 Cr -0.9% 7.3% 52.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,597.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,195.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,712.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹113,423.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,195.0 Cr 2.5% 0.8% -8.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.9%

7.3%

52.9%

SENSEX

-1%

-4.9%

-11%


You may also like the below Video Courses